随着时间的推移,在人类接种了Plasmodium falciparum Merozoite疫苗候选人的疫苗后,抗体亲和力下降
Kristina E M Persson1,2, Jessica L Horton3, Liriye Kurtovic3
1Department of Laboratory Medicine, Lund University, Lund, Sweden.
The Journal of infectious diseases
|May 9, 2024
概括
高亲和度抗体对于长期的疟疾免疫力至关重要. 一个疟疾疫苗第一阶段试验显示,第二剂后抗体亲和力增加,但在12个月内显著下降,表明抗体维持不良.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 传染性疾病 传染性疾病
背景情况:
- 对疟疾的长期免疫力依赖于在接种疫苗后保持高亲和度抗体.
- 疟疾疫苗接种者的抗体亲和力的诱导和动力学数据有限.
- 这项研究已在澳大利亚新西兰临床试验登记处注册 (ACTRN12607000552482).
研究的目的:
- 在1期疟疾疫苗试验中,研究接种疫苗后抗体亲和力的诱导和动力学.
- 为了评估疫苗接种后的高亲和抗体随着时间的推移而维持的情况.
主要方法:
- 进行了疟疾疫苗的第一阶段临床试验.
- 在接种疫苗后的12个月期间,对参与者的抗体亲和度水平进行了监测.
主要成果:
- 在第二剂疫苗注射后,抗体亲和力显示增加.
- 在接种疫苗后的12个月内,观察到抗体亲和力的显著下降.
- 这些发现表明,长期维持高亲和抗体是一个挑战.
结论:
- 该研究强调了在疟疾疫苗接种后,高亲和抗体反应的持久性可能受到限制.
- 需要进一步的研究,以了解和改善抗疟疾保护性抗体水平的长期维持.
更多相关视频
09:57Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
Published on: August 6, 2020
6.4K
08:46Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
17.3K
相关概念视频
00:42Cross-reactivity
31.0K
Overview
31.0K
01:51Vaccinations
44.4K
Overview
44.4K
01:41Affinity and Avidity
36.0K
Overview
36.0K
01:23Immunological Memory
599
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
599
01:22Development of Immunocompetence
303
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
303